• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hydrolytic rate at low drug concentration as a limiting factor in resistance to newer cephalosporins.

作者信息

Hiraoka M, Inoue M, Mitsuhashi S

机构信息

Episome Institute, Gunma, Japan.

出版信息

Rev Infect Dis. 1988 Jul-Aug;10(4):746-51. doi: 10.1093/clinids/10.4.746.

DOI:10.1093/clinids/10.4.746
PMID:3055173
Abstract

Hydrolysis kinetics of two cephalosporinases from Citrobacter freundii and Proteus vulgaris having different affinities for cefotaxime and ceftazidime was assessed in studies with cefotaxime, ceftazidime, BMY-28142, and imipenem. The two cephalosporinase genes were cloned into strains of Escherichia coli. The production of these cephalosporinases in strains of E. coli, as well as in the derepressed mutants of C. freundii and P. vulgaris, caused a decrease in susceptibility to the newer cephalosporins. The difference in the rate of hydrolysis at a 0.1 microM concentration of substrate adequately explains the difference in antibacterial activity between cefotaxime and BMY-28142 against E. coli strains with the two cephalosporinases. The results indicate that hydrolysis rate at low substrate concentration, rather than binding with beta-lactams, would be a limiting factor in resistance. The low affinity of cephalosporinases for BMY-28142 means high stability of the agent to the enzymes at low concentration. Furthermore, outer membrane permeability affects the susceptibility of E. coli to cephalosporins synergistically with hydrolysis by cephalosporinases.

摘要

相似文献

1
Hydrolytic rate at low drug concentration as a limiting factor in resistance to newer cephalosporins.
Rev Infect Dis. 1988 Jul-Aug;10(4):746-51. doi: 10.1093/clinids/10.4.746.
2
Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidime and cefotaxime.
J Antibiot (Tokyo). 1988 Jan;41(1):86-93. doi: 10.7164/antibiotics.41.86.
3
Interaction of cefpirome and a cephalosporinase from Citrobacter freundii GN7391.头孢匹罗与弗氏柠檬酸杆菌GN7391的头孢菌素酶之间的相互作用。
Antimicrob Agents Chemother. 1989 Mar;33(3):398-9. doi: 10.1128/AAC.33.3.398.
4
Interaction of E1040 with cephalosporinase from Citrobacter freundii GN7391.E1040与弗氏柠檬酸杆菌GN7391的头孢菌素酶之间的相互作用。
Antimicrob Agents Chemother. 1989 Dec;33(12):2157-9. doi: 10.1128/AAC.33.12.2157.
5
Cefoxitin resistance by a chromosomal cephalosporinase in Escherichia coli.大肠杆菌中一种染色体头孢菌素酶介导的头孢西丁耐药性
J Antibiot (Tokyo). 1980 Sep;33(9):1037-42. doi: 10.7164/antibiotics.33.1037.
6
Antibacterial activity of T-5575, a novel 2-carboxypenam, and its stability to beta-lactamase.新型2-羧基青霉烷T-5575的抗菌活性及其对β-内酰胺酶的稳定性。
J Antimicrob Chemother. 1997 Jan;39(1):31-4. doi: 10.1093/jac/39.1.31.
7
Substitution of aspartic acid-217 of Citrobacter freundii cephalosporinase and properties of the mutant enzymes.弗氏柠檬酸杆菌头孢菌素酶中天冬氨酸-217的替换及突变酶的性质
FEBS Lett. 1990 May 21;264(2):211-4. doi: 10.1016/0014-5793(90)80250-m.
8
The comparative beta-lactamase resistance and inhibitory activity of 1-oxa cephalosporin, cefoxitin and cefotaxime.1-氧杂头孢菌素、头孢西丁和头孢噻肟的β-内酰胺酶耐药性及抑制活性比较
J Antibiot (Tokyo). 1979 Sep;32(9):909-14. doi: 10.7164/antibiotics.32.909.
9
Development of resistance to cephalosporins in clinical strains of Citrobacter spp.柠檬酸杆菌临床菌株对头孢菌素耐药性的产生
Antimicrob Agents Chemother. 1984 May;25(5):591-5. doi: 10.1128/AAC.25.5.591.
10
Naturally occurring extended-spectrum cephalosporinases in Escherichia coli.大肠杆菌中天然存在的超广谱头孢菌素酶
Antimicrob Agents Chemother. 2006 Jul;50(7):2573-6. doi: 10.1128/AAC.01633-05.

引用本文的文献

1
Antimicrobial susceptibility survey of Pseudomonas aeruginosa strains isolated from clinical sources.从临床来源分离的铜绿假单胞菌菌株的药敏调查。
J Natl Med Assoc. 2004 Aug;96(8):1065-9.
2
Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢吡肟:抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1994 Mar;47(3):471-505. doi: 10.2165/00003495-199447030-00007.
3
Interaction of E1040 with cephalosporinase from Citrobacter freundii GN7391.E1040与弗氏柠檬酸杆菌GN7391的头孢菌素酶之间的相互作用。
Antimicrob Agents Chemother. 1989 Dec;33(12):2157-9. doi: 10.1128/AAC.33.12.2157.
4
Resistance to third generation cephalosporins: the current situation.对第三代头孢菌素的耐药性:现状
Infection. 1989 Sep-Oct;17(5):333-7. doi: 10.1007/BF01650724.
5
Interaction of cefpirome and a cephalosporinase from Citrobacter freundii GN7391.头孢匹罗与弗氏柠檬酸杆菌GN7391的头孢菌素酶之间的相互作用。
Antimicrob Agents Chemother. 1989 Mar;33(3):398-9. doi: 10.1128/AAC.33.3.398.
6
Effects of beta-lactamases and omp mutation on susceptibility to beta-lactam antibiotics in Escherichia coli.β-内酰胺酶和外膜蛋白突变对大肠杆菌β-内酰胺类抗生素敏感性的影响。
Antimicrob Agents Chemother. 1989 Mar;33(3):382-6. doi: 10.1128/AAC.33.3.382.
7
Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329.头孢吡肟、头孢匹罗和头孢立定对大肠杆菌K-12和铜绿假单胞菌SC8329青霉素结合蛋白的结合亲和力比较。
Antimicrob Agents Chemother. 1991 Nov;35(11):2312-7. doi: 10.1128/AAC.35.11.2312.